MedTrace Logo

Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies

NCT00581763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2024-12-27

No results posted yet for this study

Summary

This is a study about why some people have certain types of proteins in their blood, called anti-phospholipid antibodies. The presence of these antibodies and associated complications (e.g. blood clots) are known to change over time. The purpose of this study is to evaluate these changes and improve our ability to determine the long-term outcome of affected individuals.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Emily von Scheven · University of California, San Francisco

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-05-31
Primary Completion
2019-12-20
Completion
2019-12-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00581763 on ClinicalTrials.gov